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Abstract: A vital ingredient for engineering bone tissue, in the culture dish, is the use of 
recombinant matrix and growth proteins to help accelerate the growth of cultivated tissues 
into clinically acceptable quantities. The skeletal organic matrices of calcifying marine 
invertebrates are an untouched potential source of such growth inducing proteins. They 
have the advantage of being ready-made and retain the native state of the original protein. 
Striking evidence shows that skeleton building bone morphogenic protein-2/4 (BMP) and 
transforming growth factor beta (TGF-β) exist within various marine invertebrates such as, 
corals. Best practice mariculture and the latest innovations in long-term marine invertebrate 
cell cultivation can be implemented to ensure that these proteins are produced sustainably 
and supplied continuously. This also guarantees that coral reef habitats are not damaged 
during the collection of specimens. Potential proteins for bone repair, either extracted from 
the skeleton or derived from cultivated tissues, can be identified, evaluated and retrieved 
using chromatography, cell assays and proteomic methods. Due to the current evidence for 
bone matrix protein analogues in marine invertebrates, together with the methods 
established for their production and retrieval there is a genuine prospect that they can be 
used to regenerate living bone for potential clinical use. 
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1. Introduction 
Key Issues in Regenerative Orthopaedics 
Regenerative orthopaedics is the science of building and growing large amounts of natural human 
musculoskeletal tissue in the culture dish, with an emphasis on using stem cell precursors. Entire living 
bone tissue replacements are not available in clinical practice because the quantities of tissue, needed 
in oral, maxillofacial and orthopaedic surgeries, cannot be faithfully reproduced [1]. There is another 
problem too, as the composition, anatomical structure and final function of culture-derived tissue does 
not accurately simulate the human archetype. To do this properly requires a support framework with 
features of an extracellular matrix, proteins to control development and potentiated cell types that  
re-assemble into tissues. As of now, scaffold-based tissue engineering is providing many useful 
structural environments where tissues can be reconstituted in their natural form and with normal 
functions [2–6]. However, there are two outstanding issues that need to be addressed if tissues are to 
be regenerated fully in the culture dish. The first is to recreate a blood system within the developing 
tissue and provide adequate nutrition. The second is to simulate the delivery schedule of 
developmental proteins to cells for proliferation and differentiation into whole tissues. So far, clinical 
trials implementing these factors, in the regeneration of tissues, have not led to the anticipated results, 
because it has not been possible to target the proteins at the correct physiological dosages and in a 
well-timed sequence. To ensure that enough natural quality bone is produced in the laboratory, bone 
regeneration must, ideally start with the recreation of an integrated cellular and molecular ecosystem 
made up of blood vessels, neurons, cells and regenerative biochemicals. This is vital for the proper 
simulation of tissue development derived from cell progenitors [7]. Stem cells are the ideal choice to 
begin tissue regeneration. Because tissue engineers have not been able to successfully assemble such a 
difficult composite of elements, there has been a shift in approach towards the fabrication of materials 
and structures containing proteins, which are dispersed in controlled ways, to orchestrate endogenous 
repair, remodeling and regeneration [8]. The addition of growth promoting proteins is the key to 
driving and orchestrating tissue regeneration in the culture dish. Tissue promoting proteins used in 
experimental and clinical regenerative therapies are expensive to produce. The production of proteins 
using recombinant technology is imperfect. Recombinant proteins do not have the molecular 
modifications that are introduced during normal, routine genetic processing by native human cells. 
This has made it difficult to make genuine native proteins with their entire set of evolved functions. 
Thus, there are good scientific reasons for developing relatively straightforward, low cost alternatives. 
Marine invertebrates are one potential, an unexamined source of select proteins with potential utility in 
strategies for regenerative medicine, in the laboratory, and possibly for the patient. We shall explain 
why this is a feasible and convincing option to follow. To give this message strength and clarity, it is 
important to highlight the fact that proteins have been retained during the progressive increments in 
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evolutionary history. There are also some persuasive examples where proteins can interchange 
between evolutionary distant organisms. 
2. The Earliest Proteins and Genes Have Been Safeguarded throughout Animal Evolution 
Less intricate organisms at the base of the evolutionary tree such as, marine invertebrates may seem 
an unlikely resource for the bone tissue engineer, but they display a significant richness and diversity 
of intact frameworks, metabolic products, enzymes, signaling proteins, glycosaminoglycans, sterol 
lipids, extracellular matrix components and structural biomaterials that can usefully function in human 
physiology [9–11]. Many of these factors listed have almost identical functions in marine invertebrates 
and humans. This is supported by data that shows the physiological functions of some ancient proteins, 
operating in lower vertebrates, are identical to the human version of the protein, despite the existence 
of structural and compositional differences [12].  
Nature is a consummate innovator but key innovations are often preserved rather than completely 
re-designed. In one instance, insulin from Carp has been used to treat diabetes in humans. It is 
recognized as being the closest analogue of any other animal derived insulin including pig. The amino 
acid sequence of insulin, in some invertebrates, is similar to human insulin and regulates physiological 
levels of sugars in the human body [12]. Developmental proteins are some of the earliest proteins in 
evolution and are strongly preserved. Their roles have been selected time and time again. The 
embryonic pattern forming proteins, Decapentaplegic (dpp) and 60A are generated in Drosophila. 
Sections of the protein are identical to vertebrate skeleton building bone morphogenic protein-2/4 
(BMP’s). The amino acid sequence of this section shares 70%–75% similarity with human BMP2/4 
and 5/6 respectively. This is mirrored in the function of the protein as well. When concentrated 
preparations of dpp were injected into rat muscle they spontaneously invoked bone formation  
(Figure 1) [13]. 
Figure 1. Bone formation in mammals is made possible with a bone inductive protein 
analogue derived from an invertebrate. In this example, a protein from Drosophila 
development and an analogue of skeleton building bone morphogenic protein-2/4 (BMP), 
was injected into the muscle of a mouse, generating new bone. The histological section on 
the left shows osteoinduction in living mouse subcutaneous tissue following treatment with 
Drosophila Decapentaplegic (dpp). New bone tissue has been reproduced shown in purple. 
On the right, for comparison is a histological section of untreated mouse subcutaneous 
tissue. (Reproduced with permission from PNAS, Sampath et al. 1993 [13]). 
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Marine derived glycosaminoglycans (GAG) such as, Heparin sulphate are already being advocated 
as safer replacements for human obtained GAGs [10]. Although, marine invertebrate tissues are the 
simplest in composition and structural organization in the animal kingdom, they harness the 
biomolecular tool kit for the most basic and essential physiological processes and functions that exist 
in more highly evolved human tissues. To fully comprehend the molecular and structural similarities 
present between marine invertebrates and humans we need to compare and contrast all the sets of gene 
products and proteins. 
Marine invertebrates evolved a larger than at first pre-supposed genome by natural selection. It was 
always considered that the size of a genome was related to the complexity of an organism. Their 
genome is involved in producing a large number of gene duplicates, which generate a quantity of 
refined protein alternatives. Sequencing of a marine sponge genome has shown notable congruence 
with other animal genomes [14]. This molecular reservoir of functional proteins in marine dwelling 
invertebrates supports the sizeable chemical diversity of secondary metabolites to out-compete peers, 
stifle predators and adapt dynamically to changes in environment. Sequence data from marine 
invertebrate genomes, such as corals, will ensure that clear comparisons can be made of the similarities 
to human genes [15]. Identified similarities will show which gene controlled processes and functions 
that the marine invertebrate and humans have in common. This will also require analysis of the 
transcriptome using the latest RNA sequencing methods [16]. Knowing the detail of the organism’s 
genetic constitution and what genes are switched on and off during biological processes tells us what 
to expect about the degree of richness of other molecules that arise from the genetic programming. 
Additional study and molecular manipulation is required to determine when these genes are turned on, 
how they are regulated and how much they express. We must be also sufficiently thorough in our gene 
analysis to describe splice variants and isoforms, because these actions modify the protein structures 
and functions. Proteins are the key machine parts that make biological processes work properly, as 
they have evolved to do so, and fit the purpose. So, to understand the functional outcomes of marine 
invertebrate gene activities it is necessary to accurately catalogue the proteins that are made by them. 
This is done using tools developed by scientists engaged in proteomics. 
3. Preservation of Proteins during the Evolutionary History of Biomineralization 
The level of molecular complementarity between invertebrates and humans is brought into focus by 
tracking the stepwise developments during the evolution of skeletal biomineralisation from its 
inception in the Cambrian, around 500 million years ago. Mineralisation in organisms evolved many 
times independently during this geological period. This strongly implies that the molecular elements at 
the heart of skeletal calcification-signal transmitters, inhibitors, promoters, capacitors, transcription 
factors in organisms during this period of rapid evolution were favored by natural selection pressures. 
This led to the adoption of the same pioneering molecular mechanisms in every calcifying organism 
since, throughout the evolution of biomineralization [17]. These basic machine components for the 
mineralization of biological tissues are found in, corals, sponges, molluscs and vertebrates, with slight 
modifications added stepwise with each evolutionary innovation. Together they undertake the 
fundamental procedures for mineralizing the organic skeletal template.  
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There must be a strong possibility that key proteins, already linked to all calcifying animals are 
paired to those that exact fundamental tasks in the different stages of human bone mineralization-within 
bone matrices—such as, bone morphogenic proteins and osteonectin [18,19]. Some of the growth 
promoting molecules, principally peptides, used in the early stages of skeletal development have been 
discovered, already. A good example is the presence of an analogue to human osteonectin—alternatively 
named, SPARC found in species of marine sponge and Cnidarians. The osteonectin from these marine 
invertebrates possessed the same basic molecular organization and functions, in extracellular matrix 
adhesion, as their human equivalent [18,19]. This is not an isolated example. The rules of molecular 
evolution in organisms dictate with regularity, preservation of molecules rather than continued 
evolution of new ones. So, there will be other instances where proteins will have emerged by 
evolutionary innovations within developing lineages and clades. 
There are other unique examples where identical keystone developmental proteins occur between 
primitive and advanced organisms. So for instance, the blood vessel forming VEGF and its 
complementary VEGF-Receptor are present in jellyfish [20]. Bone regeneration proteins BMP2/4 
prevalent in vertebrate bone chemistry are also found in marine invertebrates such as, corals [21]. 
Within coral skeletons, BMP2/4 have been implicated in increasing organic matrix production by 
calcioblastic epithelial cells and its secretion into the compartmentalized calcifying medium  
(Figure 2A) [21]. BMP2/4 has been localized using immunohistochemistry in the calciodermis, which 
is the outward facing epithelium. Corals possess a rich organic matrix composition with probable 
regenerative, osteoactive, calcification and ECM proteins. They also harbor lipids, polysaccharides and 
glycosaminoglycans (GAGs). All these molecules are embedded within skeletal and extracellular 
organic matrices (e.g., mesoglea, desmocytes and historical matrix secretions within the bulk skeleton) 
that participate in skeletal morphogenesis [22]. Ensembles of proteins are secreted by corals within the 
extracellular matrix and into the skeleton at the mineralizing front by epidermal cells (Figure 2A). The 
distribution occurs extensively as rivulets throughout the coral skeleton (Figure 2B). 
The secretion of growth factors into the skeleton occurs throughout adult life to offset frequent 
tissue loss and damage due to predation, disease and dynamic changes in their physical and chemical 
environment. Corals have a strong capacity to properly and fully regenerate their skeletons, following 
tissue degradation and damage and so have the skeletal proteins, for reconstruction, continually 
available [23]. Cell-to-cell signaling networks that are vital for the construction and development of 
calcified tissue in vertebrate bone, Wnt, TGF-β, notch and hedgehog are also used in the same way by 
calcareous marine sponges [24].  
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Figure 2. (A) A cross-sectional diagram through the living tissue portion of a coral and 
showing the interface with the exoskeleton. The calcioblastic epithelium secretes the 
organic matrix probably embedded within intracellular vesicles into micron or nanometric 
sized spaces. Biological control of mineralization is strongly implicated in corals in other 
ways. There are semi-permeable tight septate junctions between the cells that control ion 
transport and other molecules according to size and charge (After Allemand et al. [22]). 
The calcioblastic epithelium effectively facilitates the laying down of the inorganic 
skeleton; (B) Acridine orange staining of the organic matrix of Acropora sp. skeleton, 
which appears strong yellow at the growing region and green deeper inside the skeleton. 
The pale yellow regions are the centres of calcification. This microscope image was taken 
under polarized light and shows the global distribution of intra-skeletal organic matrices 
throughout the entire skeleton [25]. The coral tissue has been removed to view this organic 
matrix. (Reproduced with permission from the Institute of Paleobiology, Polish Academy 
of Sciences, Gautret et al. 2000 [25]). 
 
4. Marine Bioprospecting for Skeletal Matrix Proteins 
Many marine organisms are enriched in what we now know to be a wealth of unique molecules that 
participate in development, metabolism and defense. There is also likely to be undiscovered molecules 
as well. Sessile marine organisms with highly developed chemical defences, have been systematically 
exploited as sources of potent secondary metabolite drug compounds [26]. However, the availability of 
such metabolites is severely limited and they are too intricate to convert into synthetic analogues. So 
far, yields of these clinically relevant chemical compounds are predominantly too low to be of any practical 
medical use. Other, non-metabolic structural and morphogenic proteins are likely to be more prevalent. 
Making use of whole organisms as providers of useful biomedicines is subject to many restrictions. 
The collection of organisms from the wild is labor intensive, time consuming and costly to carry out. 
The collection is made more difficult because the distribution of candidate marine invertebrates can 
often be patchy. Also, the mass of tissues from a selected species is usually too low to justify the effort 
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in harvesting [27]. There is also a considerable risk that once interesting therapeutic biomolecules are 
retrieved from the chosen marine invertebrate there may not be sufficient amounts for commercial 
scale development, processing and clinical use [27]. Often these therapeutic chemical compounds may 
also only be present in organisms growing in specific environmental conditions [28]. These facts have 
dissuaded pharmaceutical companies to abandon their natural product harvesting programs. At another 
level—marine conservation—it is important to select candidate marine organisms having a wide 
geographical distribution and low ecological significance, so that collecting them does not degrade 
levels of biodiversity. There are effective ways of tackling these problems such as, by rearing the 
marine organism in dedicated culture tanks. To qualify, the organism must have relatively high growth 
rates, fast wound healing rates and low disease susceptibility [29]. Alternatively, it may be practically 
feasible to select, enrich and artificially cultivate marine invertebrate cells that specifically secrete 
organic matrix, mineral bound, and extracellular matrix proteins of interest [30]. It is then possible to 
tailor the growth conditions, with a high degree of control, to promote increased secretion of desired 
molecules and install multiple millions of cells into tanks of growing media. The technological expertise is 
available and whole organisms can be farmed viably inside protected ex situ coastal nurseries [31,32] 
dissuading pharmaceutical companies to abandon their natural product harvesting programs.  
A significant number of marine invertebrates produce biochemicals within extracellular matrices 
and connective tissues, with like-for-like molecular structures, building block sequences and functions 
to human versions [18,19]. On this basis, it is therefore hypothesized that skeletal proteins in 
biomineral growth, maintenance and repair could offer the current tissue engineer a repertoire of 
proteins—with human physiological activity—that can help accelerate lab-based bone morphogenesis 
and increase bone volumes with equivalent potency to current recombinant proteins, or perhaps exceed 
them. The biggest obstacle to success will be to find ways of producing the desired protein in large 
amounts. Recombinant methods do not work well with some genes and do not have the capacity to 
modify the protein structure and composition in the same way as non-bacterial, eukaryocyte cells do. 
Using engineered expression vectors to overproduce the protein is feasible when they are small in size. 
Skeletal proteins with regenerative potency may also be used to complement treatments with such 
recombinant proteins.  
5. Marine Invertebrates Are Sources of Proteins for Regenerative Orthopaedics 
We proceed to investigate how discovering and retrieving key developmental proteins in skeletal 
calcification, from marine invertebrates might proceed and how the extracted proteins might be used as 
candidates for replacements and adjuncts to existing growth promoting proteins, currently used in the 
production of clinically acceptable therapeutic human bone. Since marine organisms have evolved, by 
natural selection, a significant molecular resource for building, adapting and repairing calcified 
skeletal tissues, they could in-turn provide a clinically acceptable cluster of proteins that help 
accelerate the growth of human bone from precursor cells in tissue culture and within the patient’s  
own skeleton.  
There is published data to show that essential growth factor proteins function within selected 
marine invertebrate tissues. These are identical to growth factors present within human mineralized 
tissues. Three orders of marine invertebrates—corals, molluscs and marine sponges—have been most 
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studied in this regard (Table 1). However, we still do not know the total number and complete set of 
proteins within any marine invertebrate. Still there has been partial characterization of the amino acid 
composition and molecular weights of proteins for selected coral and marine sponge extracellular 
organic matrices (Tables 2 and 3). These do give hints, simplistically, to protein identities via there 
molecular weights alone.  
Table 1. Growth factor protein equivalents: A list of principal growth factors used in 
regenerative orthopaedics and their marine invertebrate equivalents. 
Growth factor in 
bone matrix 
Normal role in bone 
Marine invertebrate 
species with growth 
factor analogue 
Normal role in selected marine 
invertebrate 
Bone morphogenic 
protein  
(BMP-2, BMP-4) 
A keystone regulator of embryonic 
pattern formation. A key regulator of 
bone induction, maintenance and  
repair [33]. 
Corals:  
Turbinaria reniformis, 
Acropora sp.,  
Pavona cactus,  
Galaxea fascicularis,  
Hydnophora pilosa,  
Stylophora pistillata, 
Lobophyllia sp. [21,34]. 
Secreted by calcifying epithelium 
during adult skeletogenesis [35]. 
Larva and polyp axial patterning 
in embryogenesis [35]. 
Transforming growth 
factor (TGF-β)-like 
class 
A vital regulator of embryonic pattern 
formation. A key regulator of bone 
induction, maintenance and 
repair [33]. 
Marine sponge [36]: 
Amphimedon 
queenslandica 
Ctenophore [37]: 
Mnemiopsis leidyi 
Mollusca [38]: 
Planorbarius corneus, 
Viviparus ater,  
Viviparus contectus, 
Lymneae stagnalis,  
Mytilus galloprovincialis. 
TGF-β ligands and TGF signal 
pathway components (e.g., 
SMAD) in early development 
and embryo patterning [39]. 
Vascular endothelial 
growth factor 
(VEGF) 
A cell signaling protein that induces 
vasculogenesis and  
angiogenesis [39]. 
Cnidaria:  
Podocoryne carnea [20]. 
VEGF signal pathway elements 
involved in morphogenesis of 
tentacle and gastrovascular 
canals. 
Fibroblast growth 
factor (FGF) 
ECM signaling protein that activates 
important pathways in skeletal 
development and regulate 
chondrogenesis and osteogenesis.  
A powerful angiogenic factor [40]. 
Cnidaria:  
Nematostella vectensis 
[41]. 
 
FGF ligands and receptors 
present where they function in 
gastrulation and development of 
chemosensory apical organ of 
ciliary larvae [42].  
Insulin like growth 
factor  
(IGF1-IGF2) 
Linchpin in stimulating bone 
formation and remodeling. Regulates 
chondrocyte growth and metabolism. 
Stimulates collagen synthesis.  
Site-directed recruitment of 
osteoblasts [39]. 
Nacre seashell:  
Haliotis laevigata [43]. 
Nacre perlustrin has homology 
with N-terminal domain of 
mammalian insulin-like growth 
factor binding proteins 
(IGFBPs) [43]. 
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Table 1. Cont. 
Tissue necrosis 
factor (TNF) 
Inflammation cytokine and regulator of 
immune cells. One role is as a potent 
actor in bone re-modeling. It carries out 
this function through the MAPK 
pathway which, controls differentiation 
and proliferation through JNK mediator. 
It is also prominent regulator of 
osteoclastogenesis [39]. 
TNF-α present in  
Mytilus edulis [44,45]. 
Their immunocytes 
respond to TNF in same 
manner as human 
granulocytes. 
Cytokine analogues present in 
Mytilus edulis neural 
tissue [44,45]. 
 
Epithelium growth 
factor (EGF) 
A vital regulator of bone cell 
metabolism in formation and  
resorption [46]. 
Marine sponge:  
Lubomirskia baicalensis 
[47]. 
Genes coding for  
EGF-like molecules expressed 
for patterning silica structural 
modules
 
Platelet derived 
growth factor 
(PDGF) 
A keystone regulator of cell division and 
growth. It is vital inductive signal in 
tissue remodeling morphogenesis and 
cell differentiation. It is a potent 
mitogen for bone cells. It also functions 
as a chemotactic factor for MSC and 
osteoblasts [48]. 
Mollusca [48] 
Planorbarius corneus,  
Viviparus ater,  
Viviparus contectus,  
Lymneae stagnalis,  
Mytilus galloprovincialis. 
Stimulate chemotaxis and 
phagocytic activity of wound 
repairing Molluscan 
immunocytes [48]. 
 
Table 2. Proteins separated from organic matrices in coral skeletons by molecular weight. 
Coral 
species 
MW banding in 
kDa 
Reference 
Amino acid 
compositions 
Protein gel chromatography 
Synularia 
polydactyla 
(spicules) 
109, 83, 70, 63, 
41, 30, 22 
Rehman et al. 
2005 [49]. 
 
Sequencing of  
70 kDa and 63 kDa 
proteins. 
 
Enriched acidic 
amino acids. 
 
70: glutamate;  
63: glycine. 
 
Reproduced with permission from 
Wiley-VCH Verlag GmbH, 2005 [49]. 
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Table 2. Cont. 
Galaxea 
fascicularis 
53, 45 
Fukuda et al. 
2003 [50].  
Rich in cysteine 
(dicysteine 
repeat pattern) 
Aspartate and 
asparagine. 
 
Reproduced with permission from  
Elsevier Inc., 2003 [50]. 
Balanophyllia 
europaea 
IOM and SOM: 
14.4, 13.9, 66  
 
Goffredo et al. 
2011 [51].  
 
SOM: high 
acidic amino 
acids.  
IOM: high 
hydrophobic 
residues. 
 
Reproduced with permission from  
PLoS One [51]. 
Stylophora 
Pistillata 
 
Pavona 
Cactus 
 
55, 37, 47, 68, 50, 
47, 37, 33 
(from column 1: 
silver staining) 
Puverel et al. 
2005 [52].  
 
SOM: Soluble 
organic matrix. 
 
Reproduced with permission from 
Elsevier Inc., 2005 [52]. 
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Table 2. Cont. 
C. rubrum 
 
 
 
C. konojoi 
 
 
 
C. secundum 
 
 
 
C. elatius 
(A): 6 bands at 81, 
55, 47, 44, 12 and 
10 kDa; 
 
(B): 6 bands at 53, 
45, 43, 31, 11.5 and 
10.5 kDa;  
 
(C): 5 bands at 44, 
42, 31, 11 and  
10.5 kDa;  
 
(D): 4 bands at 43, 
33, 11.5 and  
10 kDa. 
Deubreil  
et al. [53]. 
 
 
Reproduced with permission from 
Springer 2011 [53]. 
Table 3. Proteins separated from organic matrices in marine sponges by molecular weight. 
Marine sponge species MW banding in kDa Reference Amino acid compositions 
Astroscleria willeyana 
(A coralline demosponge) 
33–41 Jackson et al. 2006 [54] Not characterised 
We can be increasingly confident that the approach, to harness proteins from marine invertebrate 
skeletons will be beneficial for strategies in bone regeneration. This is because the best evidence yet, 
came to light, when nacre organic matrix proteins were shown to instigate human bone formation.  
Nacre Organic Matrix Proteins Can Promote Bone Formation in Humans 
Proteins derived from the skeletal organic matrix of nacre seashell have been shown, repeatedly, to 
promote the skeletal building activities of human bone cells, both in the culture dish and in a patient. 
The pioneering surgery only happened once. It included nacre particles, which were used to plug and 
seal a mandibular bone void. The nacre promoted regeneration of new bone contiguous with existing 
native bone [55]. Extra studies incorporating bone cells with nacre, in the petri-dish, provided evidence 
that the observed osteoinduction was probably due to the release of a mobile cell signaling peptide, 
eminating from the skeletal organic matrix [56]. Proteins extracted and then separated from the organic 
matrix showed similarities with bone growth peptides. To test this notion concentrated extracts of the 
skeletal organic matrix were infused into media bathing un-specialized cultured cells and resulted in 
their trans-differentiation into osteoblast like cells. The active soluble matrix fraction was found to 
consist of low molecular weight molecules. Using size exclusion and anion exchange HPLC, four 
defined fractions were identified, enriched in alanine and glycine. According to Almeida et al. [57] 
molecules present in one of these fractions are involved in driving the commitment of cells into the 
osteoblast lineage which is closely related to the TGF-β molecular superfamily of growth factors and 
BMP, because of the correspondence in biochemical responses of treated bone cells in vitro to those 
same molecules [58,59]. So far, there is no conclusive data to match the amino acid sequences of nacre 
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organic matrix peptides and these prominent osteogenic proteins operating in human bone matrix. 
Very recently four proteins derived from SPM of nacre, distinct from the previous studies in this 
matter, were identified as having homologous sequences to the bone re-modeling factors, Wnt 
inhibitor factor (WIF) and tenascin C [60]. 
6. Use of Proteomic Methods to Retrieve Clinically Relevant Matrix Proteins 
Proteomics will be an important tool for the discovery, characterization and analysis of medically 
useful marine derived proteins. Proteome studies begin by applying rigorous fractionation technologies 
and steps—designed through trial and error optimization—for each sample type and source [61]. These 
methods provide the most precise evaluation of protein identities, composition, abundance, cell surface 
modifications and vital function including protein expression profiling [62,63].
 
The analysis of protein compositions in the organic matrices of many marine invertebrates has been 
limited because of the difficulties in separating them by molecular weight and acidic range [64]. In a 
handful of studies there have been surveys of protein molecular weights, isoelectric points (Tables 2 
and 3), molecular bonding and amino acid compositions of organic matrices, both soluble and 
insoluble-mineral bound [63–65]. Classical chromatography is often the first step in deriving purified 
homogenous native proteins and protein fractions in preparation for proteomic analysis. These provide 
more manageable levels of fractionated proteins from specific regions of the proteome. It is especially 
important in studies where one needs to maintain the activity of desired protein such as, in marine 
products drug discovery research programs. One area of major interest for the bone tissue engineer is 
discovering a set of proteins that can individually and collectively manipulate stem cell proliferation 
and differentiation. Then use this control to induce osteomorphogenesis accurately and rapidly. 
In assessing the cell acting potential of retrieved proteins it is vital that cell-based assays are carried 
out, such as with mesenchymal stem cells. These are the prime stem cell type used in experimental 
tissue engineering of bone. The best sequence of steps to follow is first, identify proteins of interest 
using classical chromatography to group them according to molecular weight and electrical charge, 
then use them in assays to determine how the stem cells respond and to precisely identify their amino 
acid composition using sophisticated analytical machines. Chromatography is designed to separate 
proteins into clearly resolved isolates both before and after cell-based proliferation and differentiation 
assays have been carried out. Proteins with defined osteoactive roles on stem cell populations can be 
retrieved following duplication of separation and cell assays. To ensure maximized accuracy of amino 
acid sequencing the sample has to be eventually fractionated to homogeneity. The composition of the 
protein is cross-checked with existing databases of human proteins to discover its analogue. It is also 
perfectly feasible that proteins with osteoactive potency may not have a human counterpart. Stable 
isotope labeling by amino acids in cell culture (SILAC) and Isobaric tag for relative and absolute 
quantitation (iTRAQ) tagging methods, together with RNAseq profiling, to catalogue the entire 
complement of RNA, can be used to prepare a global portfolio of the stem cell proteome, following 
their treatment with marine invertebrate proteins. When measured serially over time, it then allows us 
to chart the protein interaction networks generated, in response to the addition of the marine 
invertebrate proteins. Such an approach provides us with more accurate and realistic information about 
the status of the treated cell and the nature of its activity. 
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The application of proteomic analysis and profiling could increase the efficiency of screening new 
candidate molecules from a large set of extracted proteins and how they are modified after translation. 
The utility of proteomic analysis will be dictated by how much the original sample retrieved from the 
organism has to be fractionated to reduce its complexity and the dynamic range of protein 
concentration available for analysis. The potential to do this has been demonstrated recently in an 
experimental study to characterize the biochemical make-up of bone matrix proteins [66]. This study 
demonstrates how it is possible to characterize an entire set of proteins in a nanoscale sample of source 
bone material. It also lays out a thorough blueprint for examining the biochemical make-up of organic 
matrices in mineralized tissues even at low levels of abundance—1%–2% [66]. Use of the proteomic 
techniques just described, in marine product chemistry, has not been extensive and this is also reflected 
in the paucity of protein databases that exist for these organisms. So far there have been a handful of 
notable studies that employed a proteomic approach to analyze protein secretions from the skeletal 
organic matrix of marine organisms, namely on Nautilus, Stony coral and Abalone shell [67–69]. 
Probing and analyzing the proteome can reveal surprises. The principal one has been to uncover many 
new, unknown proteins. For example, 82 entirely new proteins were retrieved from the matrix of sea urchin 
tooth; the further surprise was that they had specific roles specified by their anatomical location [70]. 
7. Conclusions 
Biologists have known that the basic proteins (and sugars such as, GAGs) involved in building 
human skeletal tissues are also the same types used in building simple marine invertebrate skeletons. 
In Table 1, we provided a list of evidence showing that major growth factor proteins—with varying 
degrees of participation in human skeletal formation—and commonly used in tissue engineering 
strategies, are also present in marine invertebrates. The most prominent regenerative proteins so far 
identified are TGF-β and BMP-2/4. These molecules play a comprehensive role in development of 
tissues. The invertebrate analogues are almost identical to the human protein in that they have similar 
building block compositions and functions.  
Marine invertebrates express a high degree of chemical and structural diversity. This includes a 
broad range of protein and sugar (GAGs, carbohydrates and lectins) molecules that participate in 
development, signaling, metabolism and regeneration. These organisms are more accessible models for 
a laboratory-based study of molecular processes and events during biomineralization. This compared 
to larger, more complicated orders of invertebrates and vertebrates. It is also feasible to extract enough 
protein to be able to analyze and sequence effectively using proteomic techniques including mass 
spectrophotometry. The combined use of chromatography, cell assays and proteomics could provide an 
effective means of discovering therapeutically significant human analogues. Therefore, the use of 
simple marine invertebrates could potentially provide the rapid development of low-cost, ready-made 
osteoinductive molecules as well as structural matrix materials for musculoskeletal tissue engineering 
to potentially replace and augment the use of some recombinant human growth factors and human 
ECM molecules.  
Methods for in situ marine aquaculture that are more compatible with their host growth 
requirements will be pivotal in the future to facilitate sustainable, large-scale production of organic 
matrix protein production. Traditional methods are still the best, because they are easier to implement 
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and have the lowest costs. Locating ideal areas for growing invertebrates along the coast is uniquely 
challenging. However, tightly controlled environments can be organized for lab-based cultivation of 
marine invertebrate candidates. Lessons need to be learnt on what constitutes the best growing 
conditions for each particular species of marine invertebrate. The aim of all this, is to grow marine 
invertebrates that secrete a specific protein of therapeutic importance. It is also feasible to grow marine 
invertebrates where genes for a desired protein, of therapeutic importance, are programmed to over 
express the protein. For the bone tissue engineer the key molecules sought from the skeletal organic 
matrices and extracellular matrices are analogues of growth factors, calcifying promoters, regulators 
and adhesive peptides. There needs to be certainty and confidence that the functions of the substitute 
invertebrate protein are identical to their human counterpart. Some studies have shown that certain 
proteins from one organism can function normally in another distantly related organism. 
A rational argument against exploiting the protein products from marine invertebrates is that the 
harvested yields can often be too low in quantity to justify the concerted effort necessary for 
collection, extraction, purification, concentration and biological testing. Judicious selection is 
necessary to avoid targeting marine invertebrate candidates, which are ecologically significant 
keystone species or listed as endangered. The use of laboratory-based marine invertebrate cell and 
tissue explant culture methods, in lab-based mariculture, will eventually circumvent these serious 
drawbacks. In controlled laboratory environments there is the potential to rigorously control the 
environment, to promote and regulate secretions of the desired protein. In the longer term this would 
be more of an advantage than growing whole organisms. However, it has been difficult to establish 
long-term cell lines and generate ideal growing media to sustain them. 
The combined present day effectiveness of mariculture, to cultivate whole marine organisms, 
marine invertebrate cell culture to generate soluble proteins directly in the culture dish and proteomic 
analysis will guarantee the most efficient use and maximized potency for marine invertebrate 
originated regenerative proteins. Crucially, it will maximize the availability of these proteins without 
damaging and degrading precious coral reef habitats. 
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